Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07436078 · ClinicalTrials.gov registry record · NA
Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
A NA study of Prostate Cancer and Colorectal Carcinoma, sponsored by Barbara Ann Karmanos Cancer Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 85
- Enrollment target
- 1
- Study location
NCT07436078: Recruiting NA study of Prostate Cancer and Colorectal Carcinoma, sponsored by Barbara Ann Karmanos Cancer Institute.
NCT07436078 is a NA study of Prostate Cancer and Colorectal Carcinoma that is actively recruiting participants, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 85 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07436078, a NA study of Prostate Cancer and Colorectal Carcinoma, is actively recruiting participants, sponsored by Barbara Ann Karmanos Cancer Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to culturally adapt an educational genetic counseling intervention to increase the uptake in genetic counseling and testing among African Americans at risk for heredity cancers. With the help of community stakeholders and clinical genetic professionals the investigators will: * adapt and refine a culturally relevant online educational genetic counseling program for at-risk African Americans * Test the effects of the educational program * collaborate with community leaders and clinical genetic professionals to translate study findings, develop a road map for dissemination to the community, and identify barriers to prepare for future trials. Participants from Detroit Research on Cancer Survivor group will be offered enrollment. Once consent is obtained, questionnaires will be completed before an online genetic counselling intervention immediately after, and at 3 months
Primary Outcome
One item question will ask whether participants have participated in genetic counseling and genetic testing (Yes or No)
Conditions Studied
Interventions
- BEHAVIORAL Culturally adapted Online Genetic Counseling and Testing Information
Study Locations (1)
Michigan
- Karmanos Cancer Institute - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2026-04 |
| Est. Completion | 2029-07 |
| Phase | NA |
What NCT07436078 shows while recruiting
NCT07436078 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (86% lower).
The record links to 3 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Culturally adapted Online Genetic Counseling and Testing Information is the first listed.
NCT07436078 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT07436078 about?
NCT07436078 is a clinical study titled "Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors". The goal of this clinical trial is to culturally adapt an educational genetic counseling intervention to increase the uptake in genetic counseling and testing among African Americans at risk for heredity cancers. With the help of community stakeholders and clinical genetic professionals the investig...
What is the current status of trial NCT07436078?
This trial is currently recruiting. It is a NA study. The enrollment target is 85 participants. The study started on 2026-04. Estimated completion is 2029-07.
What conditions does trial NCT07436078 study?
This clinical trial studies the following conditions: Prostate Cancer, Colorectal Carcinoma, Female Breast Cancer.
What interventions are being tested in trial NCT07436078?
The interventions under investigation include: Culturally adapted Online Genetic Counseling and Testing Information (BEHAVIORAL).
Who is sponsoring clinical trial NCT07436078?
This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07436078 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07436078's enrollment target sits among peer trials
85 364th of 735 higher than 372 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia